In an effort to better understand how the inner ear can hear the quietest of noises, researchers from Yale University ...

A new study from Oregon Health & Science University is the first to suggest that binaural pitch fusion—a process that ...

RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...

Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on providing hearing loss sufferers with innovative solutions today announces additional patents for its growing ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report) ...

Cochlear (ASX: COH) shares are trading at the lowest level since December 2023 after the company reported a ...

Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at ...

Cochlear (ASX: COH) shares fell as much as 12% after a second consecutive earnings miss, with earnings impacted by ...

Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...

The Cochlear Ltd (ASX: COH) share price is sinking on Friday after the hearing solutions company's half year result ...